Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6782 | 1368 | 35.3 | 72% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | OTOTOXICITY | Author keyword | 267 | 43% | 35% | 473 |
| 2 | CISPLATIN OTOTOXICITY | Author keyword | 34 | 93% | 1% | 13 |
| 3 | OTOPROTECTION | Author keyword | 25 | 54% | 2% | 32 |
| 4 | HEARING S | Address | 12 | 42% | 2% | 23 |
| 5 | VESTIBULOTOXICITY | Author keyword | 7 | 57% | 1% | 8 |
| 6 | AMINOGLYCOSIDE | Author keyword | 7 | 11% | 4% | 59 |
| 7 | HEI OC1 CELLS | Author keyword | 5 | 63% | 0% | 5 |
| 8 | OTOTOXICITY MONITORING | Author keyword | 5 | 63% | 0% | 5 |
| 9 | D METHIONINE | Author keyword | 5 | 37% | 1% | 10 |
| 10 | AMINOGLYCOSIDE TOXICITY | Author keyword | 4 | 47% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | OTOTOXICITY | 267 | 43% | 35% | 473 | Search OTOTOXICITY | Search OTOTOXICITY |
| 2 | CISPLATIN OTOTOXICITY | 34 | 93% | 1% | 13 | Search CISPLATIN+OTOTOXICITY | Search CISPLATIN+OTOTOXICITY |
| 3 | OTOPROTECTION | 25 | 54% | 2% | 32 | Search OTOPROTECTION | Search OTOPROTECTION |
| 4 | VESTIBULOTOXICITY | 7 | 57% | 1% | 8 | Search VESTIBULOTOXICITY | Search VESTIBULOTOXICITY |
| 5 | AMINOGLYCOSIDE | 7 | 11% | 4% | 59 | Search AMINOGLYCOSIDE | Search AMINOGLYCOSIDE |
| 6 | HEI OC1 CELLS | 5 | 63% | 0% | 5 | Search HEI+OC1+CELLS | Search HEI+OC1+CELLS |
| 7 | OTOTOXICITY MONITORING | 5 | 63% | 0% | 5 | Search OTOTOXICITY+MONITORING | Search OTOTOXICITY+MONITORING |
| 8 | D METHIONINE | 5 | 37% | 1% | 10 | Search D+METHIONINE | Search D+METHIONINE |
| 9 | AMINOGLYCOSIDE TOXICITY | 4 | 47% | 1% | 7 | Search AMINOGLYCOSIDE+TOXICITY | Search AMINOGLYCOSIDE+TOXICITY |
| 10 | HAIR CELL DEATH | 4 | 56% | 0% | 5 | Search HAIR+CELL+DEATH | Search HAIR+CELL+DEATH |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INDUCED OTOTOXICITY | 69 | 54% | 7% | 90 |
| 2 | OTOTOXICITY | 57 | 23% | 16% | 220 |
| 3 | GENTAMICIN OTOTOXICITY | 40 | 57% | 3% | 47 |
| 4 | PIG IN VIVO | 38 | 69% | 2% | 33 |
| 5 | PRACTICAL GRADING SYSTEM | 38 | 93% | 1% | 14 |
| 6 | RECEIVING CISPLATIN | 36 | 71% | 2% | 29 |
| 7 | D METHIONINE | 34 | 65% | 2% | 33 |
| 8 | CIS PLATINUM OTOTOXICITY | 29 | 88% | 1% | 14 |
| 9 | CISPLATIN OTOTOXICITY | 28 | 51% | 3% | 39 |
| 10 | CISPLATIN INDUCED OTOTOXICITY | 28 | 46% | 3% | 45 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Understanding platinum-induced ototoxicity | 2013 | 19 | 49 | 73% |
| Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: A systematic review of the literature | 2015 | 1 | 55 | 76% |
| Ototoxicity: therapeutic opportunities | 2005 | 125 | 54 | 85% |
| Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models | 2012 | 20 | 29 | 83% |
| Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies | 2009 | 63 | 93 | 65% |
| Mechanisms of cisplatin ototoxicity: theoretical review | 2013 | 14 | 50 | 58% |
| Ototoxicity | 2007 | 74 | 20 | 80% |
| Aminoglycoside induced ototoxicity | 2008 | 74 | 55 | 47% |
| Aminoglycoside antibiotics | 2000 | 304 | 133 | 44% |
| Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: A systematic review | 2013 | 7 | 32 | 72% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HEARING S | 12 | 42% | 1.7% | 23 |
| 2 | VESTIBULOCOCHLEAR | 4 | 20% | 1.4% | 19 |
| 3 | NEURODEV GENET | 3 | 45% | 0.4% | 5 |
| 4 | VIRGINIA MERRILL BLOEDEL HEARING | 3 | 10% | 1.9% | 26 |
| 5 | SECT CELL STRUCT FUNCT | 2 | 44% | 0.3% | 4 |
| 6 | MCGILL AUDITORY SCI | 2 | 27% | 0.5% | 7 |
| 7 | EAR GRP | 2 | 36% | 0.3% | 4 |
| 8 | VA RRD REHABIL AUDITORY | 2 | 43% | 0.2% | 3 |
| 9 | PEDIAT IMMUNOL ONCOL | 1 | 50% | 0.1% | 2 |
| 10 | LESS | 1 | 29% | 0.3% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000233044 | PRESBYCUSIS//NOISE INDUCED HEARING LOSS//AGE RELATED HEARING LOSS |
| 2 | 0.0000110885 | NEPHROTOXICITY//SERV FARMACOL TOSSICOL//CISPLATIN NEPHROTOXICITY |
| 3 | 0.0000109985 | HAIR CELL REGENERATION//HAIR CELL//OTOCYST |
| 4 | 0.0000108879 | COCHLEAR BLOOD FLOW//INNER EAR BLOOD FLOW//VESTIBULAR BLOOD FLOW |
| 5 | 0.0000105222 | STRIA VASCULARIS//ENDOLYMPH//ENDOLYMPHATIC SAC |
| 6 | 0.0000087081 | GENTAMICIN//GENTAMICIN INDUCED NEPHROTOXICITY//GENTAMICIN NEPHROTOXICITY |
| 7 | 0.0000071617 | AMINOGLYCOSIDES//AMIKACIN//TOBRAMYCIN |
| 8 | 0.0000071347 | SUDDEN SENSORINEURAL HEARING LOSS//IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS//SUDDEN HEARING LOSS |
| 9 | 0.0000068307 | LABYRINTHINE FISTULA//ELECTRIC BONE CONDUCTION//EXTENDED HIGH FREQUENCY AUDIOMETRY |
| 10 | 0.0000057147 | PRESTIN//STEREOCILIA//OUTER HAIR CELL |